Literature DB >> 20501952

Early tumor dissemination, but late metastasis: insights into tumor dormancy.

Martin Röcken1.   

Abstract

The classical model of metastasis is that tumor cell dissemination occurs late in tumor development, after the primary tumor has grown, and that only then will tumor cells invade the local tissue, enter the blood or lymphatic vessels, and colonize new sites to cause metastases. However, evidence increasingly indicates that single tumor cells spread to distant sites much earlier than previously believed. In this issue of the JCI, Eyles and colleagues provide new insight into the mechanisms underlying early tumor cell dissemination, formation of metastases, and tumor immunosurveillance using transgenic mice that spontaneously develop melanomas of the uvea. The authors provide striking evidence that tumor cells start to disseminate during the initial steps of tumor development, that late appearing metastases arise from these early disseminated tumor cells, and that CD8+ T cells inhibit the growth of disseminated tumor cells, surprisingly, not by cytotoxic effects, but through cytostatic effects.

Entities:  

Mesh:

Year:  2010        PMID: 20501952      PMCID: PMC2877965          DOI: 10.1172/JCI43424

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  22 in total

1.  Natural killer cells activated by MHC class I(low) targets prime dendritic cells to induce protective CD8 T cell responses.

Authors:  Ralph Mocikat; Heidi Braumüller; Alain Gumy; Oliver Egeter; Heike Ziegler; Uwe Reusch; Anja Bubeck; Jacques Louis; Reinhard Mailhammer; Gert Riethmüller; Ulrich Koszinowski; Martin Röcken
Journal:  Immunity       Date:  2003-10       Impact factor: 31.745

2.  A cancer immunosurveillance controversy.

Authors:  Zhihai Qin; Thomas Blankenstein
Journal:  Nat Immunol       Date:  2004-01       Impact factor: 25.606

3.  Fatal melanoma transferred in a donated kidney 16 years after melanoma surgery.

Authors:  Rona M MacKie; Robin Reid; Brian Junor
Journal:  N Engl J Med       Date:  2003-02-06       Impact factor: 91.245

4.  IFNgamma and lymphocytes prevent primary tumour development and shape tumour immunogenicity.

Authors:  V Shankaran; H Ikeda; A T Bruce; J M White; P E Swanson; L J Old; R D Schreiber
Journal:  Nature       Date:  2001-04-26       Impact factor: 49.962

5.  Cytolytic T-cell clones against an autologous human melanoma: specificity study and definition of three antigens by immunoselection.

Authors:  A Knuth; T Wölfel; E Klehmann; T Boon; K H Meyer zum Büschenfelde
Journal:  Proc Natl Acad Sci U S A       Date:  1989-04       Impact factor: 11.205

Review 6.  The concept of immunological surveillance.

Authors:  F M Burnet
Journal:  Prog Exp Tumor Res       Date:  1970

7.  Sporadic immunogenic tumours avoid destruction by inducing T-cell tolerance.

Authors:  Gerald Willimsky; Thomas Blankenstein
Journal:  Nature       Date:  2005-09-01       Impact factor: 49.962

Review 8.  Immunosurveillance, regeneration and oncogenesis.

Authors:  R T Prehn
Journal:  Prog Exp Tumor Res       Date:  1971

Review 9.  Early cancer cell dissemination and late metastatic relapse: clinical reflections and biological approaches to the dormancy problem in patients.

Authors:  G Riethmüller; C A Klein
Journal:  Semin Cancer Biol       Date:  2001-08       Impact factor: 15.707

10.  Detection of melanoma cells displaying multiple genomic changes in histopathologically negative sentinel lymph nodes.

Authors:  Anja Ulmer; Jörg R Fischer; Stefan Schanz; Karl Sotlar; Helmut Breuninger; Klaus Dietz; Gerhard Fierlbeck; Christoph A Klein
Journal:  Clin Cancer Res       Date:  2005-08-01       Impact factor: 12.531

View more
  39 in total

1.  Changing T-cell enigma: cancer killing or cancer control?

Authors:  Thomas Wieder; Heidi Braumüller; Ellen Brenner; Lars Zender; Martin Röcken
Journal:  Cell Cycle       Date:  2013-08-26       Impact factor: 4.534

2.  Metastasis and the evolution of dispersal.

Authors:  Tazzio Tissot; François Massol; Beata Ujvari; Catherine Alix-Panabieres; Nicolas Loeuille; Frédéric Thomas
Journal:  Proc Biol Sci       Date:  2019-11-27       Impact factor: 5.349

3.  Targeting USP7 Identifies a Metastasis-Competent State within Bone Marrow-Resident Melanoma CTCs.

Authors:  Monika Vishnoi; Debasish Boral; Haowen Liu; Marc L Sprouse; Wei Yin; Debalina Goswami-Sewell; Michael T Tetzlaff; Michael A Davies; Isabella C Glitza Oliva; Dario Marchetti
Journal:  Cancer Res       Date:  2018-07-19       Impact factor: 12.701

Review 4.  Genetic factors in metastatic progression of cutaneous melanoma: the future role of circulating melanoma cells in prognosis and management.

Authors:  A Ireland; M Millward; R Pearce; M Lee; M Ziman
Journal:  Clin Exp Metastasis       Date:  2011-02-11       Impact factor: 5.150

5.  Rapid generation of NY-ESO-1-specific CD4+ THELPER1 cells for adoptive T-cell therapy.

Authors:  Simone Kayser; Cristina Boβ; Judith Feucht; Kai-Erik Witte; Alexander Scheu; Hans-Jörg Bülow; Stefanie Joachim; Stefan Stevanović; Michael Schumm; Susanne M Rittig; Peter Lang; Martin Röcken; Rupert Handgretinger; Tobias Feuchtinger
Journal:  Oncoimmunology       Date:  2015-05-21       Impact factor: 8.110

6.  T-helper-1-cell cytokines drive cancer into senescence.

Authors:  Heidi Braumüller; Thomas Wieder; Ellen Brenner; Sonja Aßmann; Matthias Hahn; Mohammed Alkhaled; Karin Schilbach; Frank Essmann; Manfred Kneilling; Christoph Griessinger; Felicia Ranta; Susanne Ullrich; Ralph Mocikat; Kilian Braungart; Tarun Mehra; Birgit Fehrenbacher; Julia Berdel; Heike Niessner; Friedegund Meier; Maries van den Broek; Hans-Ulrich Häring; Rupert Handgretinger; Leticia Quintanilla-Martinez; Falko Fend; Marina Pesic; Jürgen Bauer; Lars Zender; Martin Schaller; Klaus Schulze-Osthoff; Martin Röcken
Journal:  Nature       Date:  2013-02-03       Impact factor: 49.962

7.  Impact and mechanism of non-steroidal anti-inflammatory drugs combined with chemotherapeutic drugs on human lung cancer-nude mouse transplanted tumors.

Authors:  Weiyi Sun; Gang Chen
Journal:  Oncol Lett       Date:  2016-04-25       Impact factor: 2.967

8.  Evaluation of a multi-marker immunomagnetic enrichment assay for the quantification of circulating melanoma cells.

Authors:  James B Freeman; Elin S Gray; Michael Millward; Robert Pearce; Melanie Ziman
Journal:  J Transl Med       Date:  2012-09-15       Impact factor: 5.531

9.  Smouldering malignant melanoma and metastatic dormancy: an update and review.

Authors:  Gérald E Piérard; Claudine Piérard-Franchimont; Marie-Annick Reginster; Pascale Quatresooz
Journal:  Dermatol Res Pract       Date:  2011-11-02

10.  Biological stoichiometry in tumor micro-environments.

Authors:  Irina Kareva
Journal:  PLoS One       Date:  2013-01-22       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.